Labiotech.eu

News and Trends 8 Sep 2022

Lutris Pharma radiation trial brings positive results for breast cancer patients

Top line results from a clinical trial treating breast cancer patients with radiation dermatitis (RD) have been positive. Lutris Pharma, based in Israel, is a biopharma company focused on improving cancer therapies. It announced its results from the open label part 1 and double blinded part 2 of it phase 1/2 trial yesterday (September 7). […]

September 8, 2022 - 4 minutesmins - By Liza Laws

News and Trends 8 Sep 2022

From tobacco to table – cell-cultured meat venture receives $10M funding to scale-up production

Cell cultured meat could now be produced on a broader scale thanks to funding of $10 million invested in the Israeli start-up BioBetter Ltd. Food-tech BioBetter Ltd., received the significant injection of capital in its series A round of funding which was led by Jerusalem Venture Partners (JVP) with additional investment from Milk and Honey […]

September 8, 2022 - 3 minutesmins - By Liza Laws

News and Trends 8 Sep 2022

Report looks at the future of clinical trials

Medidata, a Dassault Systèmes company, has published a report, ‘European Industry Research Report: The Future of Clinical Trials’. The report draws on new independent research that includes insights from 400 clinical trial executives across the U.K., France, Germany and Switzerland. They were surveyed to gain a deeper understanding of how clinical trials have changed over […]

September 8, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 8 Sep 2022

Omnio receives funding for wound treatment

Swedish company Omnio AB has shown plasminogen is a pro-inflammatory regulator of inflammation that can be used to treat chronic wounds with dysfunctional inflammation. The company, a spin off from Umeå University, said the drug could mean a global treatment revolution for wounds that never heal. Non-healing chronic wounds are a major global health problem […]

September 8, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 8 Sep 2022

OncoBone signs deals with three partners to work on bone metastases

OncoBone Ventures has signed cooperation framework agreements with three partners. The company is a U.K. start up biotech looking to develop novel therapies for cancer patients with currently incurable bone metastases. The partners are: Okayama University in Japan, the University of Bradford in the U.K., and The Development Center for Biotechnology in Taiwan. The agreements […]

September 8, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 8 Sep 2022

Arcutis Biotherapeutics acquires Ducentis BioTherapeutics in deal worth up to $400M

Arcutis Biotherapeutics, Inc. has entered into an agreement to acquire Ducentis BioTherapeutics Ltd., a privately held, preclinical-stage biotechnology company focused on developing novel therapies for inflammation and autoimmune diseases. Arcutis BioTherapeutics will acquire the outstanding shares of Ducentis for an upfront cash payment of approximately $16 million and Arcutis stock valued at approximately $14 million, […]

September 8, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 8 Sep 2022

Cultivated Biosciences raises $1.5M to take fats to the next frontier

Cultivated Biosciences, an ingredient startup biotech company founded by Swiss entrepreneurs Tomas Turner and Dimitri Zogg, has just raised a $1.5M pre-seed round. The funding will enable the growing team to further optimize its production processes, research food applications and start product development of its creamy ingredient for dairy alternatives from non-GMO yeast with their […]

September 8, 2022 - 2 minutesmins - By Jim Cornall

More News! 7 Sep 2022

Powerful, organic turmeric produced by controlled fermentation process

A controlled fermentation process has been used to produce an organic turmeric – a natural herb known for its health benefits and organoleptic properties. German pharmaceutical company, Cellavent, has recently entered the fermented botanical space with product, fermentlife Turmeric. Cellavent says its product is a powerful new organic turmeric that can offer a wide range […]

September 7, 2022 - 2 minutesmins - By Liza Laws

News and Trends 7 Sep 2022

Oncopeptides receives grant for NK-cell engager project in multiple myeloma

Oncopeptides AB has received a SEK 5 million ($465,000) research grant from Sweden’s Innovation Agency. The Swedish biotech company, which focuses on R&D of therapies for difficult-to-treat hematological diseases, will use the funds to develop a preclinical proof of concept (PoC) for a novel synthetic small polypeptide for the treatment of multiple myeloma. The compound […]

September 7, 2022 - 2 minutesmins - By Jim Cornall

In Depth 7 Sep 2022

The biggest private biotech investments in August 2022

The healthcare-focused companies Orna Therapeutics, F2G and Sironax bagged the biggest biotech investments in August 2022, with mRNA vaccines, genomics and fermentation technology attracting big funding rounds. As many took a well-deserved vacation in the month of August 2022, the world of biotech remained busy with fundraising. Sit back and browse our lists of the […]

September 7, 2022 - 3 minutesmins - By Jonathan Smith

News and Trends 7 Sep 2022

Lesaffre acquires genome editing company Recombia Biosciences

Lesaffre has acquired Recombia Biosciences, a biotech company based in the San Francisco Bay Area founded in 2019 based on technology licensed from Stanford University. This acquisition is the culmination of a strategic partnership initiated in 2020 to leverage Recombia Biosciences’ genome-editing technologies and accelerate the development of yeasts for sustainable production of fermented ingredients. […]

September 7, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 7 Sep 2022

Adocia takes steps with implants for treatment of type 1 diabetes

French biopharma company Adocia has established a first proof of concept for its AdoShell Islets implant by achieving glycemic control without insulin injections in immunocompetent diabetic rats during a 132-day study. AdoShell Islets is an immuno-protective synthetic biomaterial containing islets of Langerhans. After implantation in diabetic animals, the islets encapsulated in AdoShell secrete insulin in […]

September 7, 2022 - 4 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Lutris Pharma radiation trial brings positive results for breast cancer patients

From tobacco to table – cell-cultured meat venture receives $10M funding to scale-up production

Report looks at the future of clinical trials

Omnio receives funding for wound treatment

OncoBone signs deals with three partners to work on bone metastases

Arcutis Biotherapeutics acquires Ducentis BioTherapeutics in deal worth up to $400M

Cultivated Biosciences raises $1.5M to take fats to the next frontier

Powerful, organic turmeric produced by controlled fermentation process

Oncopeptides receives grant for NK-cell engager project in multiple myeloma

The biggest private biotech investments in August 2022

Lesaffre acquires genome editing company Recombia Biosciences

Adocia takes steps with implants for treatment of type 1 diabetes

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!